Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-098525
Filing Date
2024-08-19
Accepted
2024-08-19 16:12:22
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlis-20240630.htm   iXBRL 10-Q 1186398
2 EX-10.3 tlis-ex10_3.htm EX-10.3 12283
3 EX-10.6 tlis-ex10_6.htm EX-10.6 39244
4 EX-10.7 tlis-ex10_7.htm EX-10.7 39653
5 EX-31.1 tlis-ex31_1.htm EX-31.1 15881
6 EX-31.2 tlis-ex31_2.htm EX-31.2 16897
7 EX-32.1 tlis-ex32_1.htm EX-32.1 9573
8 EX-32.2 tlis-ex32_2.htm EX-32.2 10564
9 GRAPHIC img154781639_0.jpg GRAPHIC 3948
10 GRAPHIC img155705160_0.jpg GRAPHIC 3948
  Complete submission text file 0000950170-24-098525.txt   5015845

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240630.xsd EX-101.SCH 866275
59 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240630_htm.xml XML 677178
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40047 | Film No.: 241220664
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)